Baricitinib vs Mecasermin
Baricitinib vs Mecasermin: Overview
This comparison examines the pharmacological differences between Baricitinib and Mecasermin.
Mechanism of Action
Baricitinib: Selective JAK1 and JAK2 inhibitor blocking cytokine signaling involved in inflammation.
Pharmacokinetics
Half-life: Baricitinib — 12 hours.
Chemical Properties
Molecular Formula: Baricitinib — C16H17N7O2S.
Molecular Weight: Baricitinib — 371.4170 g/mol.
Type: Baricitinib — Small molecule; Mecasermin — Protein.